News Sanofi

Equities

SAN

FR0000120578

Market Closed - Euronext Paris Other stock markets 11:36:46 2024-04-23 am EDT			After market 03:59:06 pm
88.85 ^EUR	+0.77%		88.9	+0.06%

09:57pm	Sector Update: Health Care Stocks Rise Late Afternoon	MT
09:40pm	Sector Update: Health Care	MT

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Sector Update: Health Care Stocks Rise Late Afternoon	03:57pm	MT
Sector Update: Health Care	03:40pm	MT
Sanofi Asks Banks to Pitch for Roles on Separation of Consumer Health Care Business	02:00pm	MT
Sanofi Is Said To Ask Banks To Pitch For $20 Billion OTC Spinoff - Bloomberg News	12:46pm	RE
CAC40: up sharply, back over 8100 pts	11:58am	CF
CAC40: back to 8100, E-Stoxx to 5000, Nasdaq +1.5	11:11am	CF
CAC40: closes in on 8,100, well supported by W-Street	10:02am	CF
CAC40: up slightly after encouraging PMI figures	05:02am	CF
Sanofi: positive phase III data in IPT	03:04am	CF
Sanofi Reports Positive Results from Phase 3 Trial of Rilzabrutinib for Immune Thrombocytopenia	01:45am	MT
Sanofi Says Blood-Disorder Drug Meets Key Target in Late-Stage Trial	01:39am	DJ
Sanofi Reaches $100 Million Settlement for US Lawsuits Over Zantac Cancer Claims	01:22am	MT
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia	01:02am	GL
Press Release: Rilzabrutinib LUNA 3 phase 3 study met primary endpoint in immune thrombocytopenia	01:00am	AQ
Sector Update: Health Care Stocks Rise in Monday Afternoon Trading	Apr. 22	MT
European Equities Close Higher in Monday Trading; EC Probes TikTok Over Possible DSA Violations	Apr. 22	MT
Top Midday Stories: Verizon Shares Down, Truist Shares Up Post Earnings; CNH Industrial Names New Chief Executive; Tesla Dissolves Newly Created Marketing Team	Apr. 22	MT
Sanofi to Pay More Than $100 Million to Settle 4,000 Suits Alleging Zantac Causes Cancer	Apr. 22	MT
Sanofi Reportedly Agrees to Settle Zantac Cancer Lawsuits for More Than $100 Million	Apr. 22	MT
SANOFI : Gets a Buy rating from UBS	Apr. 22	ZD

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

SANOFI : Looking beyond the quarterly miss, Sanofi remains an attractive bet

February 01, 2024 at 11:26 am EST

Sanofi Sees Trend for Years of Steady Growth: CFO

February 03, 2023 at 03:56 pm EST